MenüForum-NavigationForumMitgliederAnmeldenRegistrierenForum-Breadcrumbs - Du bist hier:ForumFlohmarkt: Schuheدهانات المدينة مصراتةAntwortenAntworten: دهانات المدينة مصراتة <blockquote><div class="quotetitle">Zitat von Gast am 31. März 2026, 14:51 Uhr</div>[url=https://www.homes.com/property/38-brookins-green-dr-orchard-park-ny/de6fqfq45eme2/]Zoya Demidenko[/url]: Scholar in Cancer Studies [url=https://uk.linkedin.com/in/berezutskayahttps://www.homes.com/property/38-brookins-green-dr-orchard-park-ny/de6fqfq45eme2/]Zoya Demidenko[/url] is a prominent investigator affiliated with the Department of Cell Stress Science at Roswell Park Oncology Institute in Buffalo, New York. Previously, she was employed at the National Institutes of Health and New York Medical College, developing a robust background in biomedical study. Her scientific contributions encompasses a number of pivotal fields, encompassing the PI3K/AKT/mTOR signaling cascade, cell cycle management, cell senescence, and cancer science. As of now, she has co-authored over 46 peer-reviewed papers, which have accumulated upwards of 4,100 citations — a reflection to the influence of her work. Among her most notable discoveries involves explaining the mechanisms of biological cell aging. Her research showed that when the cell cycle is halted yet cellular expansion proceeds, cells undergo senescence. Significantly, [url=https://www.instagram.com/zoyamonros/]Zoya Demidenko[/url] showed that this process can be pharmacologically suppressed using compounds such as mTOR inhibitors. [url=https://aacrjournals.org/cancerres/article/65/16/7386/518098/Depletion-of-Mutant-p53-and-Cytotoxicity-of?guestAccessKey=]Zoya Demidenko[/url] has additionally added greatly to oncological therapy investigation, notably in the area of selective cell protection — a method designed to protecting healthy cells from anticancer drugs whilst leaving malignant cells exposed. This approach offers major hope for reducing the toxic effects of oncological therapy. Throughout her professional journey, Demidenko has partnered with top scientists internationally, such as Dr. Mikhail Blagosklonny. Her work can be found in leading publications such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene. [31.03.2026 11:21] Папа: Holding an h-index of 33, [url=https://www.aging-us.com/article/100421/]Zoya Demidenko[/url] ranks as a influential contributor in modern cancer science, with her discoveries go on to guide our comprehension of how biological cells grow old, interact with treatment, and the ways in which malignant disease might be more successfully targeted. https://www.pinterest.com/zoyademidenko/</blockquote><br> Abbrechen
